Health Benefits at a Glance:
Nanoemulsified Colorado Hemp Oil from Quicksilver Scientific is a positive mood supplement and brain and immune health supplement in on and the same product. It provides non-psychogenic cannabidiol derived from the hemp plant in a liposomal form. Cannabidiol can support brain health including neurotransmitter balance and mood, as well as support immune system responses. It can also support muscles, skeleton, and joint health.
Why it Works:
Nanoemulsified Colorado Hemp Oil from Quicksilver Scientific provides a standardized, and highly bioavailable form of cannabidiol. Cannabinoids, which are found in the hemp plant possess neuroprotective properties and have been shown to be able to support mood-, and neurotransmitter-balance as well as supporting immune system responses [4, 6, 7]. Moreover, cannabinoids can also support the function of muscles, skeleton, and support joint health [8, 9]. In other words, it is a positive mood supplement and a brain and immune health supplement in on and the same product
Cannabinoids have been shown to have a broad impact on the body, which can influence gene expression in more than 1000 genes in the body. Cannabinoids have also been shown to regulate the expression of certain cellular antioxidant defenses by influencing specific pathways (e.g. Nrf2), while simultaneously inhibiting inflammatory signaling molecules .
Furthermore, the nanoemulsified formula improves the bioavailability and absorbability of cannabidiol in compared to other supplements. Due to higher bioavailability and absorbability of cannabidiol, plasma levels can be up to 5 times higher than that of other oral liquids containing cannabinoids. This is because the nanoemulsified particles enable delivery of the biologically active substances directly into the circulation, and also enhances delivery into the cells.
The Science Behind the Product:
The body is full of cannabinoid receptors of the types CB1 and CB2. These cannabinoid receptors are found in greater numbers in the hippocampus, the central nervous system, the immune system, and the peripheral nervous system . Cannabinoid receptors are affected by the endogenous compounds 2-arachidonoylglycerol and anandamide [2, 3]. The immune- and nervous system both produce endocannabinoids which can activate both the CB1 and CB2 receptors . If taken orally cannabinoids can increase the levels of endocannabinoids and also bind to cannabinoid receptors.
Furthermore, Quicksilver Scientific’s unique delivery system (Quicksilver Delivery Systems™) brings cutting-edge liposomal and emulsification technology into the formula. In practical terms this means that the particles (the active ingredients in the product) are both smaller and more stable. This in turn enhances the absorption rate of the active ingredients. This entails that these nanoemulsified particles both enhance lymphatic circulation and can be delivered more easily inside the cells [10, 11]. Finally, the phospholipids (of which each individual liposomal vesicle is made), nourishes the cell membranes and promote their proper function for the absorption of nutrients as well as the excretion of cellular waste products and various kinds of toxins .
How to Use:
- Take 2 to 4 pumps by mouth up to 4 times daily. Hold in mouth 30 seconds before swallowing. Repeat to desired dosage or as directed by healthcare professional. Take on empty stomach, at least 10 minutes before meals. May be stirred into small amount of water. Use within 60 days of opening. If pregnant, consult physician before use.
- Juknat A, et al. Br J Pharmacol. 2012;165(8):2512-28.
- Pertwee R, et al. Pharmacol Rev. 2010;62(4):588-631.
- Blankman JL, et al. Chem Biol. 2007 Dec;14(12):1347-56.
- McCoy KL. Mediators Inflamm. 2016;2016:5831315.
- Hampson AJ, et al. Ann N Y Acad Sci. 2000;899:274-82.
- Gordon E, Devinsky O. Epilepsia. 2001 Oct;42(10):1266-72.
- Resstel LB, et al. Br J Pharmacol. 2009 Jan;156(1):181-8.
- Costa B, et al. Eur J Pharmacol. 2007 Feb 5;556(1-3):75-83.
- Malfait AM, et al. Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9561-6.
- Ahn H, Park JH. Biomater Res. 2016 Nov 23;20:36.
- Alyautdin R, et al. Int J Nanomedicine. 2014 Feb 7;9:795-811.
- Spector AA, Yorek MA. J Lipid Res. 1985 Sep;26(9):1015-35